The coronavirus vaccine was developed faster than any vaccine in history. It took just 332 days from the first sequencing of the virus genome to the first vaccines given to the public.
L’expertise universitaire, l’exigence journalistique
Articles sur FDA
Affichage de 1 à 20 de 74 articles
A new over-the-counter COVID-19 test has been authorized by the FDA. Though it can be used to test people with and without symptoms, moderate cost and limited production mean it isn't a game-changer.
Millions of Americans say they won't get the vaccine. Will money change their minds? And is luring them with cash the right approach?
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
The jury's still out on whether or not CBD relieves stress and anxiety.
Many people object to the added ingredients in vaccines. But pharmacists explain why those fears are unwarranted.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Aerosols of some FDA-approved food coloring could deactivate airborne viruses.
Consuming the plant can be lethal to animals and humans.
Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.
After firms add more women to their board, dangerous medical products are recalled more quickly.
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
Researchers are developing a seasonal shot that blocks Lyme disease-causing bacteria from a tick.
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven't been tried before.
To battle the coronavirus, strong regulatory protection from the FDA is essential.
Les contributeurs les plus fréquents
-
Assistant Professor of Law, Saint Louis University
-
Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Professor and Dean, School of Public Health, Georgia State University
-
Professor of Law, Boston University
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Researcher, Department of Animal Science, University of California, Davis
-
Assistant Professor of Operations and Decision Technologies, Kelley School of Business, Indiana University
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Postdoctoral research fellow, University of Adelaide
-
Research Leader, Critical and Ethical Mental Health research group, Robinson Research Institute, University of Adelaide
-
Senior lecturer in Pharmacology, University of Adelaide
-
Professor and Head of Clinical Research, National Centre for Immunisation Research and Surveillance, University of Sydney
-
Associate Professor, Deakin University
-
Senior Research Fellow, Bioethics, University of Sydney
